A systematic review of the budget impact analyses for antitumor drugs of lung cancer
Abstract Background Budget impact analyses (BIAs) are used for reimbursement decisions and drug access medical insurance, as a supplement to cost-effectiveness analyses (CEAs). Objectives We systematically reviewed BIAs for antitumor drugs of lung cancer to provide reference for high-value drug budg...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-12-01
|
| Series: | Cost Effectiveness and Resource Allocation |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12962-020-00253-5 |